Growth of Diabetes Research in United Arab Emirates: Current and Future Perspectives

Author(s): Mohamad Shieb, Sema Koruturk, Ankita Srivastava, Bashair M. Mussa*.

Journal Name: Current Diabetes Reviews

Volume 16 , Issue 4 , 2020

Become EABM
Become Reviewer

Abstract:

Background: Diabetes mellitus (DM) is one of the most prevalent metabolic diseases in the UAE. During the last two decades, the United Arab Emirates (UAE) has experienced tremendous development in all fields including DM research. The present study sheds light on the growth in DM research in UAE and represents a guide for DM researchers to create more focused future directions in DM research.

Objectives: The main objective of the present study is to investigate and document the changes that occurred in DM research in the UAE over the last two decades.

Methods: Several research databases were reviewed and all the articles that involved any form of DM research within the UAE were selected. Inclusion criteria were: (i) Research studies related to DM and conducted by institutions based in UAE (ii) Research studies related to DM and conducted in the population of UAE and (iii) Research articles related to DM and the authors (principal investigators or co-investigators) are from UAE.

Results: Between the years of 1996 and 2000, there was an average of 6.4 articles about DM being published per year. This pattern changed dramatically between years 2011 to 2015 where an average of 22.8 articles were being published. In addition, a significant increase was noticed in the year 2015 with 42 articles published per year. It was also found that 46.8% articles involved clinical study, 12.1% were basic research, 17.5% cross-sectional studies, 8.91% reviews, 8.2% were cohort and all the other types of research represented about 5.58%.

Conclusion: Significant progress has been noticed in DM research in the UAE during the last two decades. Based on the findings of the present study, more focus should be given to the case reports and clinical trials.

Keywords: Type 1 diabetes, type 2 diabetes, diabetes complications, diabetes research in UAE, clinical research, basic research.

[1]
Diabetes Atlas IDF. International Diabetes Federation. 4th ed.Brussels, Belgium 2009.
[2]
2009 Jan; Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 27(suppl 1): s5-s10.
[3]
Stirban AO, Tschoepe D. Cardiovascular complications in diabetes: targets and interventions. Diabetes Care 2008; 31(Suppl. 2): S215-21.
[http://dx.doi.org/10.2337/dc08-s257] [PMID: 18227488]
[4]
Lim AKh. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis 2014; 7: 361-81.
[http://dx.doi.org/10.2147/IJNRD.S40172] [PMID: 25342915]
[5]
Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) 2015; 2(1): 17.
[http://dx.doi.org/10.1186/s40662-015-0026-2] [PMID: 26605370]
[6]
Modica PA. Diabetic retinopathy. Optometry -. J Am Optom Assoc 2004; 75(5): 276.
[http://dx.doi.org/10.1016/s1529-1839(04)70063-9]
[7]
Hussain N, Adrian TE. Neuropathy: Update on pathophysiological mechanism and the possible involvement of glutamate pathways. Curr Diabetes Rev 2017; 13(5): 488-97.
[http://dx.doi.org/10.2174/1573399812666160624122605] [PMID: 27341846]
[8]
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008; 88(11): 1322-35.
[http://dx.doi.org/10.2522/ptj.20080008] [PMID: 18801863]
[9]
Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 2006; 1084(1): 1-29.
[http://dx.doi.org/10.1196/annals.1372.029] [PMID: 17151290]
[10]
Graham TE, Abel ED. Autophagy in diabetes and the metabolic syndrome. Autophagy in Health and Disease 2013; pp. 117-39.
[http://dx.doi.org/10.1016/B978-0-12-385101-7.00008-5]
[11]
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab 2012; 16(7)(Suppl. 1): S27-36.
[http://dx.doi.org/10.4103/2230-8210.94253] [PMID: 22701840]
[12]
Brownie S, Hunter L, Rossiter R, Hills AP, Robb W, Hag-Ali M. Diabetes in the United Arab Emirates: the need for valid datasets for health service planning. Lancet Diabetes Endocrinol 2014; 2(7): 535-7.
[http://dx.doi.org/10.1016/S2213-8587(14)70025-7] [PMID: 24999255]
[13]
Diabetes Atlas IDF. International Diabetes Federation. 4th ed. Brussels, Belgium 2017.
[14]
Webster N. UAE spend on diabetes care falls well short of US and UK. UAE University Center for Public Policy and Leadership 2018.
[15]
Diabetes in the United Arab Emirates: Crisis or Opportunity? 2010.
[16]
Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc (2003) 2009; 49(3): 383-91.
[http://dx.doi.org/10.1331/JAPhA.2009.09015] [PMID: 19357068]
[17]
Knowledge, attitude and practices of diabetic patients in the United Arab Emirates. PLoS One 2013; 8(1)e52857
[18]
Shaalan K, Al-Mansoori M, Tawfik H. An awareness-raising E-learning approach for children living in a high diabetic population. Inform Health Soc Care 2014; 39(2): 81-103.
[http://dx.doi.org/10.3109/17538157.2013.858043] [PMID: 24517457]
[19]
Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes 2013; 4(6): 270-81.
[http://dx.doi.org/10.4239/wjd.v4.i6.270] [PMID: 24379917]
[20]
Fahim MA, Hasan MY, Alshuaib WB. Early morphological remodeling of neuromuscular junction in a murine model of diabetes. J Appl Physiol 2000; 89(6): 2235-40.
[http://dx.doi.org/10.1152/jappl.2000.89.6.2235] [PMID: 11090573]
[21]
The U.A.E. Healthcare Sector. An Update 2016.
[22]
Tawfik H, Anya O, Nagar AK. Understanding clinical work practices for cross-boundary decision support in e-health. IEEE Trans Inf Technol Biomed 2012; 16(4): 530-41.
[http://dx.doi.org/10.1109/TITB.2012.2187673] [PMID: 22345549]
[23]
Punnose J, Agarwal MM, El Khadir A, Devadas K, Mugamer IT. Childhood and adolescent diabetes mellitus in Arabs residing in the United Arab Emirates. Diabetes Res Clin Pract 2002; 55(1): 29-33.
[http://dx.doi.org/10.1016/S0168-8227(01)00267-4] [PMID: 11755476]
[24]
Al-Arouj M, Bouguerra R, Buse J, et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 2005; 28(9): 2305-11.
[http://dx.doi.org/10.2337/diacare.28.9.2305] [PMID: 16123509]
[25]
Ali S, Davies MJ, Brady EM, et al. Guidelines for managing diabetes in Ramadan. Diabet Med 2016; 33(10): 1315-29.
[http://dx.doi.org/10.1111/dme.13080] [PMID: 26802436]
[26]
Razzak HA, Harbi A, Shelpai W, Qawas A. Epidemiology of diabetes mellitus in the united arab emirates. Curr Diabetes Rev 2018; 14(6): 542-9.
[http://dx.doi.org/10.2174/1573399813666170920152913] [PMID: 28933305]
[27]
World Health Organization – Diabetes country profiles, 2016.https://www.who.int/diabetes/country-profiles/are_en.pdf?ua=1
[28]
Hills S, Halban PA. DIAMAP: a road map for diabetes research in Europe. J Diabetes Sci Technol 2011; 5(3): 794-7.
[http://dx.doi.org/10.1177/193229681100500334] [PMID: 21722595]
[29]
Country and regional data on diabetes 2018.https://www.who.int/diabetes/facts/world_figures/en/index5.html


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 4
Year: 2020
Page: [395 - 401]
Pages: 7
DOI: 10.2174/1573399815666190201114408

Article Metrics

PDF: 17
HTML: 1